Practical considerations to implement the shorter regimen to MDR-TB patients in China

被引：4
|
作者：
Liu, Q. [1 ]
Sun, F. [1 ]
Li, Y. [1 ]
Bao, J. [2 ]
Zhang, Y. [1 ,3 ]
Zhang, W. [1 ]
机构：
[1] Fudan Univ, Huashan Hosp, Dept Infect Dis, 12 WulumuqiZhong Rd, Shanghai 200040, Peoples R China
[2] NIAID, TB Clin Res Branch, Div AIDS, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2018年 / 24卷 / 10期
关键词：
MULTIDRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; BENEFIT; EUROPE;
D O I：
10.1016/j.cmi.2018.04.026
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1035 / 1036
页数：2
相关论文
共 50 条
  • [1] Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?
    Dheda, Keertan
    Cox, Helen
    Esmail, Aliasgar
    Wasserman, Sean
    Chang, Kwok Chiu
    Lange, Christoph
    RESPIROLOGY, 2018, 23 (01) : 36 - 45
  • [2] Shorter drug regimens for MDR-TB
    不详
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2016, 94 (06) : 410 - 410
  • [3] Early experience with the implementation of the WHO shorter MDR-TB treatment regimen in Singapore
    She, Hoi Wah
    Wang, Yee Tang
    Gan, Suay Hong
    Chua, Angeline Poh Gek
    Chee, Cynthia Bee Eng
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [4] Outcome of Multi drug resistant(MDR)TB patients on Shorter MDR TB Regimen
    Bajpai, Jyoti
    Bajaj, Darshan Kumar
    Kumar, Sandeep
    Kushwaha, R. A. S.
    Kant, Surya
    Verma, Ajay Kumar
    Tyagi, Richa
    Garg, Rajiv
    Srivastava, Anand
    Kumar, Santosh
    Kumar, Ankit
    Kumar, Naveen
    Dixit, Nandini
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [5] Factors affecting the treatment outcome of injection based shorter MDR-TB regimen at a referral centre in India
    Kiran, B.
    Singla, Rupak
    Singla, Neeta
    Vinay, V.
    Singh, Kuljeet
    Choudhury, Madhumita Paul
    Bhattacherjee, Nilotpal
    MONALDI ARCHIVES FOR CHEST DISEASE, 2023, 93 (03)
  • [6] Prospective study on outcome of MDR-TB using the shorter regimen during COVID-19 pandemic
    Kumar, Sravan G.
    Sameena, P.
    Karthik, V
    Ghanate, Nalini
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2023, 12 (06) : 1087 - 1091
  • [7] Does an intermittent regimen increase the risk of MDR-TB?
    Maug, A.
    Salim, M. A. H.
    Declercq, E.
    Van Deun, A.
    Blok, L.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2007, 12 : 74 - 74
  • [8] High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon
    Kuaban, C.
    Noeske, J.
    Rieder, H. L.
    Ait-Khaled, N.
    Foe, J. L. Abena
    Trebucq, A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (05) : 517 - 524
  • [9] Case Report: Kanamycin Ototoxicity and MDR-TB Treatment Regimen
    Mantefardo, Bahru
    Sisay, Gizaw
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2021, 14 : 815 - 817
  • [10] Personalized medicine for patients with MDR-TB
    Olaru, Ioana D.
    Lange, Christoph
    Heyckendorf, Jan
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (04) : 852 - 855
12345